Extensive evaluation of a seronegative participant in an HIV-1 vaccine trial as a result of false-positive PCR
Open Access
- 1 July 1997
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 350 (9073) , 256-259
- https://doi.org/10.1016/s0140-6736(97)01500-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- HIV quantification: clinical applicationsThe Lancet, 1996
- Candidate AIDS VaccinesNew England Journal of Medicine, 1995
- Utility of various commercially available human immunodeficiency virus (HIV) antibody diagnostic kits for use in conjunction with efficacy trials of HIV-1 vaccinesClinical and Diagnostic Laboratory Immunology, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Absence of Recoverable Infectious Virus and Unique Immune Responses in an Asymptomatic HIV+Long-Term SurvivorAIDS Research and Human Retroviruses, 1994
- Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infectionJournal of Clinical Microbiology, 1994
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991